Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin vs Noradrenaline as Initial Therapy in Septic Shock
2011-005363-24Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Oct 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of vasopressin in septic shock (2 arms), sponsored by Imperial College London. Primary endpoint: Renal failure–free days. Started Oct 2012; status: completed.
02
Drugs
vasopressin
03
Conditions
septic shock
Beyond the preview
Go deeper on 2011-005363-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005363-24.